Vaccines
AstraZeneca Pauses £200 Million Cambridge Expansion Amid Scrapped Vaccine Plant Plans
The British pharmaceutical giant, AstraZeneca, has paused its planned £200 million expansion of its research site in Cambridge, amid recent news of scrapped plans to invest £450 million in a vaccine plant in Merseyside. This development comes as a blow to the Government, which had been seeking to showcase its